“Uniformity of therapeutic medication rules in United States horse racing is a goal long endorsed by the AAEP, and we are eager to evaluate the newly proposed Horseracing Integrity and Safety Act to understand how the legislation will address both anti-doping and therapeutic medication control. These two pillars require oversight by individuals with a high level of expertise. The AAEP urges the bill’s sponsors to consider the requisite expertise needed within the sport’s proposed governance structure in order to ensure successful implementation across the racing landscape.

“It is more important than ever that the AAEP work together with industry stakeholders to create a workable legislative vehicle that will achieve the uniformity, safety and integrity standards we all seek for racehorses and the racing industry. The AAEP welcomes the continued opportunity to contribute to this process.”